Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Genelink
AddedFeb 20, 2024
UpdatedJun 18, 2026
Genelink

Genelink

Acquired

GeneLink, Inc. offers a DIY DNA collection kit and genetic information service, storing data for 75 years.

HQ
Orlando, FL, US
Founded
1994
Overview
Compare
Fundraising
Employees
Website

GeneLink, Inc. was founded with the mission to provide accessible and long-term genetic information storage for families. The company offers a do-it-yourself, non-invasive DNA collection kit that allows individuals to collect their DNA using dacron swabs. Once collected, the DNA samples and data forms are mailed back to GeneLink for secure storage, where they are kept for 75 years. This service is aimed at families looking to preserve their genetic information for future reference and potential medical use.

Notable figures associated with GeneLink include its founders and key investors who have supported the company’s vision of democratizing genetic information storage. GeneLink has achieved significant milestones in making DNA collection and storage more accessible to the general public, contributing to advancements in personal genetic data management. The company's impact lies in its ability to offer a reliable and long-term solution for families interested in preserving their genetic heritage.

Genelink - Similar Companies

Genomelink logo

Genomelink

genomelink.io

dna37.com logo

dna37.com

Geno.Me logo

Geno.Me

yourgeno.me

Full Genomes logo

Full Genomes

fullgenomes.com

My Gene Counsel logo

My Gene Counsel

mygenecounsel.com

Geneicd logo

Geneicd

23andMe logo

23andMe

23andme.com

GeneDx Holdings logo

GeneDx Holdings

genedx.com

Genetica logo

Genetica

genetica.asia

Geneticure logo

Geneticure

geneticure.com

Invitae logo

Invitae

invitae.com

Novogenia logo

Novogenia

novogenia.com

Gentec logo

Gentec

Geneformics logo

Geneformics

Myriad Genetics logo

Myriad Genetics

myriad.com

Genelink - Quick Facts

Who are Genelink's competitors?

Companies similar to Genelink include Genomelink, dna37.com, Geno.Me and Full Genomes.

When was Genelink founded?

Genelink was founded in 1994.

Where is Genelink's headquarters located?

Genelink's headquarters is located in Orlando, FL, US.

When was Genelink's last funding round?

Genelink's most recent funding round was for $50k (USD) in April 2013.

How much has Genelink raised to-date?

As of Apr 15, 2013, Genelink has raised a total of $1.2M (USD).

Genelink - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • DNA Kits
  • Genetics
Tags
  • eCommerce
  • Healthtech
NAICS
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
  • 620000Health Care and Social Assistance
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories
  • 8000Health Services
ISIC
  • 8690Other human health activities
Show 5 more industry codes
NAICS
  • 621512Diagnostic Imaging Centers
  • 623000Nursing and Residential Care Facilities
SIC
  • 6000Depository Institutions
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified